![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
References
- Wang E, Ni H, Xu R et al. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J. Virol. 74, 3227–3234 (2000).
- Endy TP, Chunsuttiwat S, Nisalak A et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am. J. Epidemiol. 156, 40–51 (2002).
- Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313–319 (2004).
- Murthy HM, Judge K, DeLucas L, Padmanabhan R. Crystal structure of dengue virus NS3 protease in complex with a Bowman–Birk inhibitor: implications for flaviviral polyprotein processing and drug design. J. Mol. Biol. 301, 759–767 (2000).
- Egloff MP, Benarroch D, Selisko B, Romette JL, Canard B. An RNA cap (nucleoside-2´-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. Embo. J. 21, 2757–2768 (2002).
- Warke RV, Xhaja K, Martin KJ et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J. Virol. 77, 11822–11832 (2003).
- Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc. Natl Acad. Sci. USA 100, 14333–14338 (2003).
- Medin CL, Fitzgerald KA, Rothman AL. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J. Virol. 79, 11053–11061 (2005).
- Libraty DH, Endy TP, Houng HH et al. Differing influences of viral burden and immune activation on disease severity in secondary dengue 3 virus infections. J. Infect. Dis. 185, 1213–1221 (2002).
- Beckett CG, Kosasih H, Faisal I et al. Early detection of dengue infections using cluster sampling around index cases. Am. J. Trop. Med. Hyg. 72, 777–782 (2005).
- Endy TP, Nisalak A, Chunsuttiwat S et al. Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am. J. Epidemiol. 156, 52–59 (2002).
- Wills BA, Nguyen MD, Ha TL et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N. Engl. J. Med. 353, 877–889 (2005).
- Endy TP, Nisalak A, Chunsuttitwat S et al. Relationship of pre-existing dengue virus (DV) neutralizing antibody levels to viremia and disease severity in a prospective cohort study of DV infection in Thailand. J. Infect. Dis. 189(6), 990–1000 (2004).
- Mangada MM, Endy TP, Nisalak A et al. Dengue-specific T-cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J. Infect. Dis. 185, 1697–1703 (2002).
- Hombach J, Barrett AD, Cardosa MJ et al. Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26–27 April 2004, Bangkok, Thailand. Vaccine 23, 2689–2695 (2005).
Website
- Pediatric dengue vaccine initative www.pdvi.org (Accessed September 2005)